S&P 500   4,567.00 (-1.90%)
DOW   34,483.72 (-1.86%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
S&P 500   4,567.00 (-1.90%)
DOW   34,483.72 (-1.86%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
S&P 500   4,567.00 (-1.90%)
DOW   34,483.72 (-1.86%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
S&P 500   4,567.00 (-1.90%)
DOW   34,483.72 (-1.86%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
OTCMKTS:TOBAF

TAAT Global Alternatives Stock Forecast, Price & News

$2.86
+0.17 (+6.32%)
(As of 11/30/2021 03:59 PM ET)
Add
Compare
Today's Range
$2.69
$2.94
50-Day Range
$2.25
$3.32
52-Week Range
$1.77
$4.74
Volume
294,082 shs
Average Volume
188,763 shs
Market Capitalization
$290.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.87
30 days | 90 days | 365 days | Advanced Chart
Receive TOBAF News and Ratings via Email

Sign-up to receive the latest news and ratings for TAAT Global Alternatives and its competitors with MarketBeat's FREE daily newsletter.


TAAT Global Alternatives logo

About TAAT Global Alternatives

TAAT Global Alternatives Inc. is an early-stage life sciences company. It focuses on hemp and the association with health and fitness. Its product portfolio includes Hemp cigarettes. The company was founded on June 5, 2006 and is headquartered in Vancouver, Canada.

Headlines

TAAT™ Sponsoring WallStreetBets' "To...
November 30, 2021 |  benzinga.com
TAAT™ Finalizes First Commercial Order for Austria
November 5, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry
Investors, not elsewhere classified
Sub-Industry
N/A
Current Symbol
OTCMKTS:TOBAF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
$130 thousand
Book Value
$0.11 per share

Profitability

Net Income
$-8.31 million
Net Margins
-1,356.50%
Pretax Margin
-1,361.24%

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$290.11 million
Optionable
Not Optionable

Company Calendar

Last Earnings
10/05/2021
Today
11/30/2021
Fiscal Year End
10/31/2022

MarketRank

Overall MarketRank

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












TAAT Global Alternatives (OTCMKTS:TOBAF) Frequently Asked Questions

Is TAAT Global Alternatives a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for TAAT Global Alternatives in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" TAAT Global Alternatives stock.
View analyst ratings for TAAT Global Alternatives
or view top-rated stocks.

How were TAAT Global Alternatives' earnings last quarter?

TAAT Global Alternatives Inc. (OTCMKTS:TOBAF) released its earnings results on Tuesday, October, 5th. The company reported ($0.06) EPS for the quarter. The business earned $1.06 million during the quarter. TAAT Global Alternatives had a negative net margin of 1,356.50% and a negative trailing twelve-month return on equity of 195.44%.
View TAAT Global Alternatives' earnings history
.

Who are TAAT Global Alternatives' key executives?

TAAT Global Alternatives' management team includes the following people:
  • Setti Coscarella, Chief Executive Officer & Director
  • Tim Corkum, Chief Revenue Officer

What is TAAT Global Alternatives' stock symbol?

TAAT Global Alternatives trades on the OTCMKTS under the ticker symbol "TOBAF."

How do I buy shares of TAAT Global Alternatives?

Shares of TOBAF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is TAAT Global Alternatives' stock price today?

One share of TOBAF stock can currently be purchased for approximately $2.86.

How much money does TAAT Global Alternatives make?

TAAT Global Alternatives has a market capitalization of $290.11 million and generates $130 thousand in revenue each year.

What is TAAT Global Alternatives' official website?

The official website for TAAT Global Alternatives is www.taatusa.com.

Where are TAAT Global Alternatives' headquarters?

TAAT Global Alternatives is headquartered at 1075 WEST GEORGIA STREET SUITE 2630, VANCOUVER BC, V6E 3C9.

How can I contact TAAT Global Alternatives?

TAAT Global Alternatives' mailing address is 1075 WEST GEORGIA STREET SUITE 2630, VANCOUVER BC, V6E 3C9. The company can be reached via phone at (604) 687-2038.


This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.